Figure 2.
PFS (A) and OS (B) in elderly patients in first remission of DLBCL randomized to either lenalidomide or placebo maintenance. Results from the REMARC study. Reprinted from Thieblemont et al55 with permission.
PFS (A) and OS (B) in elderly patients in first remission of DLBCL randomized to either lenalidomide or placebo maintenance. Results from the REMARC study. Reprinted from Thieblemont et al55 with permission.
